ENZOLYTICS
Enzolytics is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Enzolytics is committed to creating drugs for the better health of mankind.
ENZOLYTICS
Industry:
Health Care
Address:
Monrovia, Montserrado, Liberia
Country:
Liberia
Website Url:
http://www.enzolytics.com
Status:
Active
Contact:
(626)-538-4779
Current Employees Featured
Official Site Inspections
http://www.enzolytics.com
- Host name: 209.17.116.165
- IP address: 209.17.116.165
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258

More informations about "Enzolytics"
Enzolytics - Crunchbase Company Profile & Funding
Organization. Enzolytics . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. Enzolytics is a drug development company. Monrovia, Montserrado, โฆSee details»
Company News - Enzolytics
Enzolytics, Inc. (ENZC) Company Profile & Facts - Yahoo Finance
See the company profile for Enzolytics, Inc. (ENZC) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives โฆSee details»
Enzolytics Inc - LinkedIn
Enzolytics, Inc. is a Texas based biotech company committed to the commercialization of its proprietary proteins and monoclonal antibodies for the treatment of debilitating infectious โฆSee details»
ENZC - Enzolytics Inc. | Company Profile | OTC Markets
Mar 26, 2025 Business Description Enzolytics, Inc. (the "Company" or "ENZC") is a drug development company committed to the commercialization of its proprietary proteins for the โฆSee details»
Enzolytics (ENZC) Company Profile & Description - Stock Analysis
Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics โฆSee details»
Enzolytics Inc (ENZC) Profile - The Globe and Mail
See the company profile for Enzolytics Inc (ENZC) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Company Enzolytics, Inc. - MarketScreener.com
Mar 18, 2024 Enzolytics, Inc. is a drug development company. The Company is focused on commercializing its licensed proprietary proteins and monoclonal antibodies to treat โฆSee details»
Enzolytics - Overview, News & Similar companies | ZoomInfo.com
Mar 6, 2024 Enzolytics, Inc. is a drug development company committed to the commercialization of its proprietary proteins and monoclonal antibodies for the tre atment of debilitating infectious โฆSee details»
ENZC | Enzolytics Inc. Company Profile & Executives - WSJ
Company profile for Enzolytics Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed ENZC description & address.See details»
Enzolytics - VentureRadar
Enzolytics, Inc. is a Texas-based biotech company committed to the development and commercialization of its proprietary proteins and monoclonal antibodies for the treatment of โฆSee details»
Enzolytics 2025 Company Profile: Stock Performance & Earnings
Enzolytics General Information Description. Enzolytics Inc is a biotechnology company, whose products consist of multiple distinct drug development proprietary technologies: โฆSee details»
Our Science - Enzolytics
Enzolytics, Inc. is committed to the development and commercialization of its proprietary protein therapeutics for the treatment of debilitating infectious diseases. The Companyโs technology is โฆSee details»
Enzolytics, Inc. CONSOLIDATED BALANCE SHEETS As of December โฆ
ENZOLYTICS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Note 1. Organization and Business Enzolytics, Inc. (โEnzolyticsโ or the โCompanyโ) is a Delaware โฆSee details»
Company Enzolytics Inc. Other OTC - MarketScreener.com
Jun 15, 2017 Enzolytics, Inc. is a drug development company. The Company is focused on commercializing its licensed proprietary proteins and monoclonal antibodies to treat โฆSee details»
Enzolytics, Inc. Reports Progress and Future Plans - Yahoo Finance
Apr 25, 2022 Enzolytics continues to make significant progress in its multiple therapeutic platforms and outlines here the technical aspects of the implementation of those programs and โฆSee details»
ENZC | News | OTC Markets
Enzolytics, Inc. is transitioning from solely a drug development company committed to commercializing its proprietary proteins and monoclonal antibodies to treat debilitating โฆSee details»
Enzolytics (ENZC): Uncovering the Hidden Risks Investors Should โฆ
Nov 26, 2024 Enzolytics faces severe challenges, including limited revenue, legal scrutiny, excessive share dilution, and market competition. The companyโs inability to deliver products โฆSee details»
Enzolytics, Inc. Reports Progress and Future Plans | Nasdaq
Apr 25, 2022 Enzolytics continues to make significant progress in its multiple therapeutic platforms and outlines here the technical aspects of the implementation of those programs and โฆSee details»
5 Reasons Why Enzolytics is a Compelling Choice! - Avise Analytics
Jun 11, 2021 Enzolytics Inc. (OTCPK: ENZC) is leveraging over 40 years of drug development experience to develop proprietary antiviral peptides and monoclonal antibodies for the โฆSee details»